These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19645134

  • 41. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
    Majno P, Giostra E, Mentha G.
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S27-35. PubMed ID: 17969086
    [No Abstract] [Full Text] [Related]

  • 42. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB, Weissman J, Perkins JD.
    Clin Transplant; 2009 Nov; 23(6):874-81. PubMed ID: 19453644
    [Abstract] [Full Text] [Related]

  • 43. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
    Kobayashi A, Takahashi S, Ishii H, Konishi M, Nakagohri T, Gotohda N, Satake M, Furuse J, Kinoshita T.
    Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Approach to the treatment of primary liver cancer.
    Primrose JN.
    Med J Malaysia; 2005 Jul; 60 Suppl B():104-7. PubMed ID: 16108188
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hepatocellular carcinoma: latest developments.
    Walzer N, Kulik LM.
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [Abstract] [Full Text] [Related]

  • 48. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D, Bronowicki JP, Boudejma K, Bachellier P, Chone L, Nisand G, Bazin C, Pflumio F, Uhl G, Wenger JJ, Boissel P, Bigard MA, Gaucher P, Vetter D, Wolf P, Doffoel M.
    Wiad Lek; 1997 May; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract] [Full Text] [Related]

  • 49. Impact of staging on the treatment of hepatocellular carcinoma.
    Zornig C, Broelsch CE.
    Endoscopy; 1993 Jan; 25(1):138-42. PubMed ID: 7681000
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [New therapeutic options in the treatment of hepatocellular carcinoma].
    Martinotti R, Evangelista W, Goss M, Angelini F, Satolli MA.
    Minerva Med; 2001 Oct; 92(5):341-7. PubMed ID: 11675578
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Hepatocellular carcinoma - diagnosis and treatment].
    Greten TF, Manns MP.
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1907-10. PubMed ID: 18785082
    [No Abstract] [Full Text] [Related]

  • 54. Management of primary liver cancer.
    Prescrire Int; 2009 Feb; 18(99):33-4. PubMed ID: 19391296
    [Abstract] [Full Text] [Related]

  • 55. Treatment of hepatocellular carcinoma.
    Blum HE.
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [Abstract] [Full Text] [Related]

  • 56. Pretreatment assessment of hepatocellular cancer: expert consensus conference.
    Wilson SR, Greig P, Kaseb AO.
    HPB (Oxford); 2010 Jun; 12(5):300-1. PubMed ID: 20590902
    [No Abstract] [Full Text] [Related]

  • 57. 2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy.
    Gridelli C, Rossi A, Maione P.
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S248-57. PubMed ID: 21943982
    [No Abstract] [Full Text] [Related]

  • 58. Letter to Editor: Locoregional Therapy Before Liver Transplantation for Hepatocellular Carcinoma.
    Jiang N, Li X, Xing YF, Qiao YD, Chen J.
    Hepatology; 2019 Oct; 70(4):1490-1491. PubMed ID: 31090941
    [No Abstract] [Full Text] [Related]

  • 59. Current status of the surgical management of primary liver cancer in China.
    Chen XP, Wu ZD.
    Acta Acad Med Wuhan; 1983 Oct; 3(1):60-4. PubMed ID: 6191262
    [No Abstract] [Full Text] [Related]

  • 60. [Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors 
(2017 Edition)].
    Ye X, Fan W, Wang H, Wang J, Gu S, Feng W, Zhuang Y, Liu B, Li X, Li Y, Yang P, Yang X, Yang W, Chen J, Zhang R, Lin Z, Meng Z, Hu K, Liu C, Peng Z, Han Y, Jin Y, Lei G, Zhai B, Huang G, Minimally Invasive Treatment of Lung Cancer Branch, Professional Commitee of Minimally Invasive Treatment of Cancer, Chinese Anti-Cancer Association.
    Zhongguo Fei Ai Za Zhi; 2017 Jul 20; 20(7):433-445. PubMed ID: 28738958
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.